Meyka Pro banner
Amgen Inc.

Amgen Inc. (AMGN) Stock Overview

Explore Amgen Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMGN●NASDAQ
HealthcareDrug Manufacturers - General
$462.32
$3.35(0.72%)
U.S. Market opens in NaNh NaNm

Amgen Inc. (AMGN)

Meyka AI Score

Z

Key Financials

Market Cap250.1B
P/E Ratio26.65
EPS (TTM)$22.37
ROE0.86%
Fundamental Analysis

AI Price Forecasts

1 Month$498.96
3 Months$464.36
1 Year Target$368.27

AMGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Amgen Inc. (NASDAQ: AMGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Amgen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AMGN on the NASDAQ shows an RSI of 58.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $368.27 for the NASDAQ listing.

Key metrics behind Amgen Inc.'s NASDAQ-traded stock include a P/E ratio of 26.65 and a market capitalization of 250.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMGN on the NASDAQ.

Price Performance (NASDAQ: AMGN)

1-Day Change
-0.72%
5-Day Change
0.29%
1-Month Change
6.90%
3-Month Change
11.35%
6-Month Change
41.68%
Year-to-Date (YTD) Change
41.25%
1-Year Change
35.30%
3-Year Change
71.87%
5-Year Change
125.09%
All-Time (Max) Change
134393.09%

Contact Information

805 447 1000
One Amgen Center Drive, Thousand Oaks, CA, 91320-1799

Company Facts

315,000 Employees
IPO DateJun 17, 1983
CountryUS
Actively Trading

Frequently Asked Questions